Vincent Perrotta, MD
Plastic Surgery · Salisbury, MDNPI 1720033541
Payments from drug & device makers
What this record shows
AbbVie accounts for 69.7% of it on its own, with 21 other manufacturers making up the rest. Reporting peaked in 2019 at $2,514 and has fallen 79.1% since, to $525 in 2025.
Across 136 payments — averaging $33.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Mentor Worldwide LLC$242
- Galderma Laboratories, L.p.$242
- Sientra, Inc.$192
- Sun Pharmaceutical Industries Inc.$161
- Stryker$90
- plus $458 from 16 others
What the payments were for
- Food & beverage$2,50755%
- Gifts$2,05445%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 77 | $3,177 |
| Mentor Worldwide LLC | 9 | $242 |
| Galderma Laboratories, L.p. | 14 | $242 |
| Sientra, Inc. | 3 | $192 |
| Sun Pharmaceutical Industries Inc. | 9 | $161 |
| Stryker | 2 | $90 |
| TELA Bio, Inc. | 3 | $78 |
| DUSA Pharmaceuticals, Inc. | 3 | $59 |
| Integra Lifesciences Corporation | 2 | $50 |
| TEI Biosciences Inc | 2 | $33 |
| Smith+Nephew | 1 | $27 |
| Heron Therapeutics, Inc. | 1 | $26 |
| Revance Therapeutics, Inc. | 1 | $24 |
| Kowa Pharmaceuticals America, Inc. | 1 | $23 |
| Biofrontera Inc. | 1 | $21 |
| Kls-martin L.p. | 1 | $20 |
| Almirall LLC | 1 | $20 |
| W. L. Gore & Associates, Inc. | 1 | $18 |
| Organogenesis Inc. | 1 | $17 |
| Kerecis Limited | 1 | $15 |
| Bioventus LLC | 1 | $14 |
| Coopersurgical, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,561 in reported general payments places this provider in the 65th percentile of 105 plastic surgery providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluorouracil | 92 | $5,710 |
| Cefadroxil | 147 | $788 |
| ValacyclovirValacyclovir Hcl | 41 | $519 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 67 | $328 |
| Doxycycline Hyclate | 19 | $183 |
| Ciprofloxacin Hcl | 13 | $69 |
| Cephalexin | 16 | $60 |
Paid to pharmacies, not to this prescriber.
Other plastic surgery in Salisbury
- Thomas KerestesSalisbury$11K
- Christopher PellegrinoSalisbury$2K
- Chad GordonBaltimore$2.9M
- Larry LicksteinTowson$271K
- Sarah MessColumbia$178K
- Ricardo RodriguezLutherville$71K
- Jasson AbrahamBaltimore$54K
- Maakan TaghizadehBaltimore$38K
- Derek MasdenBaltimore$34K
- Steven RottmanBaltimore$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.